<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="helma.xsl"?>
<xmlroot xmlns:hop="http://www.helma.org/docs/guide/features/database">
  <hopobject id="2432" name="Page" prototype="Page" created="1363280116832" lastModified="1543266120511">
  <hop:parent idref="0" prototyperef="Root"/>
    <http_browser>Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.1; SV1)</http_browser>
    <lang>en-us</lang>
    <uri>bone-update</uri>
    <http_host>127.0.0.1:8080</http_host>
    <time type="date">26.11.2018 21:02:00 UTC</time>
    <pseudoparent idref="0" prototyperef="Root"/>
    <http_remotehost>127.0.0.1</http_remotehost>
    <hopsession>127.0.0.1n8tru9204maa</hopsession>
    <user>default</user>
    <pvcount type="float">85.0</pvcount>
    <body>What do you do for a living? &lt;a href=&quot;http://www.purplecreativedesign.co.uk/stmap_58840.html?viagra.suhagra.microzide.nateglinide&quot;&gt;acland street medical centre fax&lt;/a&gt;  The green light from the European Medicines Agency (EMA)paves the way for full marketing authorisation in the next twoor three months. Approval in the key U.S. market remains someway off, since the drug will not be filed there until late 2014.
 </body>
    <http_language>en-US,en;q=0.8</http_language>
    <is_xhtml type="boolean">true</is_xhtml>
    <http_referer>http://beagleboard.org/bone-update/edit</http_referer>
  </hopobject>
</xmlroot>
